Prior to joining Minghui Pharma, Gaurav served as CBO at Curate Biosciences and Head of BD for Precigen Inc. His background also includes key business development roles at Gilead Sciences, Shire Pharmaceuticals and Amgen, where he led various transactions across therapeutic areas >$20B in total deals incl. licensing, M&A and R&D collaborations and helped build large-pharma pipeline via sourcing external innovation. Serving strategic advisor to small biotech's as well. He earned his MBA from University of Michigan and his MS from Wayne State University, Michigan.